John Wiley & Sons Coronavirus Disease 2019 (Covid-19) Cover CORONAVIRUS DISEASE 2019 (COVID-19) Provides comprehensive coverage of all key aspects of COVID-19,.. Product #: 978-1-119-78968-0 Regular price: $114.02 $114.02 Auf Lager

Coronavirus Disease 2019 (Covid-19)

A Clinical Guide

Gholamrezanezhad, Ali / Dube, Michael P. (Herausgeber)

Cover

1. Auflage Januar 2023
704 Seiten, Hardcover
Praktikerbuch

ISBN: 978-1-119-78968-0
John Wiley & Sons

Jetzt kaufen

Preis: 122,00 €

Preis inkl. MwSt, zzgl. Versand

Weitere Versionen

epubmobipdf

CORONAVIRUS DISEASE 2019 (COVID-19)

Provides comprehensive coverage of all key aspects of COVID-19, including: etiology, diagnosis, symptomatology, management, and treatment

Coronavirus Disease 2019 (COVID-19): A Clinical Guide provides healthcare professionals at all levels with up-to-date knowledge about the clinical, epidemiological, genomic, virological, and radiologic features of COVID-19. Consolidating multiple systematic reviews and meta-analyses into a single volume, this comprehensive textbook also addresses health policies, mass casualty planning, healthcare worker safety, economic impact, lessons for future outbreaks, and other para-clinical and social aspects of the COVID-19 pandemic.

The text presents a thorough summary and critical analysis of COVID-19 based on an exhaustive review of recently published literature and data. Topics include the virologic characteristics of SARS-CoV-2, pulmonary and extrapulmonary manifestations and consequences of COVID-19, prevention and transmission control, the pandemic's indirect impact to the care and management of other diseases, passive immunotherapy and its implications, diagnostic and treatment approaches for critically ill patients, and more. Edited by leading ­practitioners at the forefront of COVID-19 research, this invaluable resource:
* Integrates clinical, radiological, and epidemiological data and discussion of prevention, diagnosis, and treatment
* Reviews the epidemiology, mechanisms of action, manifestations, and management of cardiovascular, neurological, and pulmonary diseases associated with COVID-19
* Covers diagnostic technologies, includes radiologic imaging, and RT-PCR testing
* Explores therapeutic approaches for managing a variety of complications
* Discusses post-vaccination symptom management and implications of immunization
* Addresses COVID-19 in pediatrics, in cancer patients, and in patients with lung disease, diabetes, ­hypertension, obesity, and other underlying conditions

Coronavirus Disease 2019 (COVID-19): A Clinical Guide is an indispensable source of information for all clinicians, researchers, epidemiologists, nurses, radiologists, and healthcare managers working to address any aspect of the COVID-19 pandemic.

Dedication

List of contributors

Preface

1 COVID-19: Epidemiology

2 COVID-19: Virology

3 COVID-19: Laboratory/Serologic Diagnostics

4 COVID-19: Radiologic Diagnosis

5 COVID-19: Pathology Perspective

6 COVID-19: Immunology

7 COVID-19: Presentation and Symptomatology

8 COVID-19: Risk Stratification

9 COVID-19: Outpatient Management of in Adults

10 COVID-19: Inpatient Management

11 COVID-19: ICU and Critical Care Management

12 COVID-19 in Pediatrics

13 Pharmacologic Therapeutics for COVID-19

14 Co-infections and Secondary Infections in COVID-19 Pneumonia

15 COVID-19: Neurology Perspective

16 COVID-19: Cardiology Perspective

17 COVID-19: Oncologic and Hematologic Considerations

18 COVID-19: Dermatology Perspective

19 COVID-19: Ophthalmology Perspective

20 COVID-19: Nutrition Perspectives

21 COVID-19: Nursing Perspective

22 COVID-19: Vaccination

23 Post-COVID-19 Vaccine Imaging Findings

24 COVID-19: Long-Term Pulmonary Consequences

25 Psychological Effects and Neuropsychiatric Sequelae in COVID-19 Patients

26 Mental Health Effects of the COVID-19 Pandemic on Healthcare Professionals

27 COVID-19: Ethical Considerations in Clinical Practice

28 Racial, Ethnic, and Other Disparities in the Epidemiology and Care of COVID-19

29 Global Impact of COVID-19 on Healthcare Systems

30 COVID-19: Mass Casualty Planning

Index
Ali Gholamrezanezhad, Associate Professor of Clinical Imaging, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, USA. Since the outbreak of the pandemic, Dr. Gholamrezanezhad has been leading an international team of researchers, physicians, and scientists to investigate COVID-19.

Michael P. Dube, Professor of Medicine, Division of Infectious Diseases, Keck School of Medicine, University of Southern California (USC), Los Angeles, California, USA. Dr. Dube has been active in clinical care and clinical trials of COVID-19 therapeutics and vaccines and serves on a variety of committees at the local and state levels addressing the pandemic.

A. Gholamrezanezhad, University of Southern California (USC), Los Angeles, California, USA; M. P. Dube, University of Southern California (USC), Los Angeles, California, USA